CSC Receives EU Approval to Acquire iSOFT

CSC

today announced it has received unconditional clearance from the European Commission to proceed with the acquisition of iSOFT, one of the world's largest providers of advanced healthcare IT solutions. EU clearance means that all regulatory consents to the transaction have been received. Completion of the transaction remains subject to gaining shareholder approval and final Court assent in Australia. Please refer to the Scheme documentation lodged with the ASX on 14 June 2011 for an indicative timetable. The acquisition, once completed, will complement and strengthen CSC's market-leading software products and healthcare integration and services portfolio, while enhancing its healthcare research and development capabilities. It will also accelerate CSC's strategic growth plan in the Life Sciences market and reinforce the company as a very strong player in healthcare information technology.